3rd Quarter - Report
OTSUKA AMERICA PHARMACEUTICAL, INC. for OTSUKA AMERICA PHARMACEUTICAL, INC.
Income
—
Expenses
$350,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Medicare Part D, 42 CFR Part 2 (CONFIDENTIALITY OF SUBSTANCE USE DISORDER PATIENT RECORDS) Polycystic Kidney Disease,Mental Health
| Lobbyist | Covered position, as disclosed |
|---|---|
| ORKIDEH MALKOC | — |
| MOLLY RYAN | — |
Medicare/Medicaid MMM
Medicare Part D Redesign, Drug Pricing (H.R.3, SFC bill PDPRA)
| Lobbyist | Covered position, as disclosed |
|---|---|
| ORKIDEH MALKOC | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.